Form 8-K - Current report:
SEC Accession No. 0001104659-25-034220
Filing Date
2025-04-11
Accepted
2025-04-11 16:16:03
Documents
51
Period of Report
2025-04-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512145d1_8k.htm   iXBRL 8-K 31736
2 EXHIBIT 99.1 tm2512145d1_ex99-1.htm EX-99.1 63343
6 GRAPHIC tm2512145d1_ex99-1img001.jpg GRAPHIC 42847
7 GRAPHIC tm2512145d1_ex99-1img002.jpg GRAPHIC 338016
8 GRAPHIC tm2512145d1_ex99-1img003.jpg GRAPHIC 184328
9 GRAPHIC tm2512145d1_ex99-1img004.jpg GRAPHIC 150297
10 GRAPHIC tm2512145d1_ex99-1img005.jpg GRAPHIC 150263
11 GRAPHIC tm2512145d1_ex99-1img006.jpg GRAPHIC 143438
12 GRAPHIC tm2512145d1_ex99-1img007.jpg GRAPHIC 131683
13 GRAPHIC tm2512145d1_ex99-1img008.jpg GRAPHIC 84634
14 GRAPHIC tm2512145d1_ex99-1img009.jpg GRAPHIC 34033
15 GRAPHIC tm2512145d1_ex99-1img010.jpg GRAPHIC 164342
16 GRAPHIC tm2512145d1_ex99-1img011.jpg GRAPHIC 147649
17 GRAPHIC tm2512145d1_ex99-1img012.jpg GRAPHIC 169876
18 GRAPHIC tm2512145d1_ex99-1img013.jpg GRAPHIC 145725
19 GRAPHIC tm2512145d1_ex99-1img014.jpg GRAPHIC 180133
20 GRAPHIC tm2512145d1_ex99-1img015.jpg GRAPHIC 142010
21 GRAPHIC tm2512145d1_ex99-1img016.jpg GRAPHIC 202356
22 GRAPHIC tm2512145d1_ex99-1img017.jpg GRAPHIC 162477
23 GRAPHIC tm2512145d1_ex99-1img018.jpg GRAPHIC 122961
24 GRAPHIC tm2512145d1_ex99-1img019.jpg GRAPHIC 160977
25 GRAPHIC tm2512145d1_ex99-1img020.jpg GRAPHIC 185421
26 GRAPHIC tm2512145d1_ex99-1img021.jpg GRAPHIC 137295
27 GRAPHIC tm2512145d1_ex99-1img022.jpg GRAPHIC 146482
28 GRAPHIC tm2512145d1_ex99-1img023.jpg GRAPHIC 144589
29 GRAPHIC tm2512145d1_ex99-1img024.jpg GRAPHIC 147704
30 GRAPHIC tm2512145d1_ex99-1img025.jpg GRAPHIC 111579
31 GRAPHIC tm2512145d1_ex99-1img026.jpg GRAPHIC 35103
32 GRAPHIC tm2512145d1_ex99-1img027.jpg GRAPHIC 139888
33 GRAPHIC tm2512145d1_ex99-1img028.jpg GRAPHIC 204244
34 GRAPHIC tm2512145d1_ex99-1img029.jpg GRAPHIC 188868
35 GRAPHIC tm2512145d1_ex99-1img030.jpg GRAPHIC 173447
36 GRAPHIC tm2512145d1_ex99-1img031.jpg GRAPHIC 145394
37 GRAPHIC tm2512145d1_ex99-1img032.jpg GRAPHIC 157499
38 GRAPHIC tm2512145d1_ex99-1img033.jpg GRAPHIC 191786
39 GRAPHIC tm2512145d1_ex99-1img034.jpg GRAPHIC 119775
40 GRAPHIC tm2512145d1_ex99-1img035.jpg GRAPHIC 32744
41 GRAPHIC tm2512145d1_ex99-1img036.jpg GRAPHIC 138805
42 GRAPHIC tm2512145d1_ex99-1img037.jpg GRAPHIC 150357
  Complete submission text file 0001104659-25-034220.txt   7690822

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cara-20250411.xsd EX-101.SCH 3038
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20250411_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20250411_pre.xml EX-101.PRE 22374
53 EXTRACTED XBRL INSTANCE DOCUMENT tm2512145d1_8k_htm.xml XML 3684
Mailing Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901
Business Address 400 ATLANTIC STREET, SUITE 500 STAMFORD CT 06901 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 25832290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)